A 58-year-old patient suffering from multiple myeloma successfully underwent Autologous Stem Cell Transplantation or Bone Marrow Transplant at Dr Bhubaneswar Borooah Cancer Institute in Guwahati (BBCI).
Myeloma is a type of blood cancer or haematological malignancy that involves specialized cells called the plasma which is responsible for the production of antibodies.
As explained by the Director of BBCI, Dr Amal Chandra Kataki, bone marrow transplantation is a medical procedure wherein stem cells are collected from the bone marrow and transplanted to the patient after appropriate conditioning treatment. It is an advanced medical procedure that involves an expert medical team along with a great infrastructure.
At BBCI this team is headed by the Department of Medical Oncology with the support of the Department of Pathology. The cost of the transplantation procedure is 60per cent to 70 per cent lower than that of in a private sector hospital.
Myeloma is a type of blood cancer or haematological malignancy that involves specialized cells called the plasma which is responsible for the production of antibodies.It was a privilege for Fit Northeast to speak to Dr Asif Iqbal, who is the Associate Professor of Haemato-Oncology division of Medical Oncology here.
During the conversation, Dr Iqbal said that the patient who has undergone bone marrow transplantation was under treatment in this pioneer institution since November 2020 and his fourth cycle of chemotherapy ended in April 2021. He was even given two chemotherapies prior to his treatment. The entire procedure started on 11 July 2021 and ended on 19 July 2021, the day when the transplant was finally completed.
It was on July 29 when his condition was showing engrafting, which means that the blood-forming cells which the person received on the transplantation day have started to grow and make healthy blood cells, which is an important milestone in recovery. The patient was monitored up to three days after the day of engraftment and there was a continuous rise in his white blood cell count. The condition of the patient has improved now.
Dr Iqbal said that bone marrow transplant is the first-line treatment in case of multiple myeloma and in times when there is a relapse in cases of acute leukaemia, lymphoma. When cases of any kind of blood cancer relapse, it becomes necessary to go for a bone marrow transplant. As symptoms of blood cancer, one might experience the swelling or inflammation of the lymph gland, anaemia, fall in the platelet count, bleeding and unexplained fever.